Published in Eur Heart J on July 04, 2005
Effect of gender difference on platelet reactivity. Neth Heart J (2011) 1.09
Thrombosis and antithrombotic therapy in women. Arterioscler Thromb Vasc Biol (2009) 1.03
Influence of sex hormones and phytoestrogens on heart disease in men and women. Womens Health (Lond Engl) (2010) 1.02
Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women. Br J Pharmacol (2014) 0.96
Sex differences in cardiovascular drug-induced adverse reactions causing hospital admissions. Br J Clin Pharmacol (2012) 0.93
Nonsteroidal anti-inflammatory drug and acetaminophen use and risk of adult myeloid leukemia. Cancer Epidemiol Biomarkers Prev (2011) 0.92
Sex-based differences in cardiac ischaemic injury and protection: therapeutic implications. Br J Pharmacol (2014) 0.91
Male mice have increased thrombotic potential: sex differences in a mouse model of venous thrombosis. Thromb Res (2011) 0.86
Should women receive left ventricular assist device support?: findings from INTERMACS. Circ Heart Fail (2012) 0.80
Gender-specific prescription for cardiovascular diseases? Eur Heart J (2005) 0.80
Evaluation of sexual dimorphism in the efficacy and safety of simvastatin/atorvastatin therapy in a southern Brazilian cohort. Arq Bras Cardiol (2014) 0.78
Bleeding and first-year mortality following hip fracture surgery and preoperative use of low-dose acetylsalicylic acid: an observational cohort study. BMC Musculoskelet Disord (2011) 0.76
Assessment of Sex Differences for Treatment, Procedures, Complications, and Associated Conditions Among Adolescents Hospitalized with Crohn's Disease. Inflamm Bowel Dis (2015) 0.75
Does i-T744C P2Y12 Polymorphism Modulate Clopidogrel Response among Moroccan Acute Coronary Syndromes Patients? Genet Res Int (2017) 0.75
Predictors of excess mortality after myocardial infarction in women. Ulster Med J (2008) 0.75
ESR1 polymorphisms and statin therapy: a sex-specific approach. Pharmacogenomics J (2015) 0.75
Strategies for improving cardiovascular health in women with diabetes mellitus: a review of the evidence. Curr Diab Rep (2015) 0.75
Factors affecting the anthelmintic efficacy of papaya latex in vivo: host sex and intensity of infection. Parasitol Res (2015) 0.75
Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med (2007) 6.23
Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med (2007) 5.14
Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry (2009) 3.33
HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeats. Nat Struct Biol (2003) 3.22
Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology (2010) 3.08
Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation (2011) 2.87
Addition of milk prevents vascular protective effects of tea. Eur Heart J (2007) 2.80
Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation (2006) 2.34
Primer: administrative health databases in observational studies of drug effects--advantages and disadvantages. Nat Clin Pract Rheumatol (2007) 2.18
Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project. Infection (2015) 2.06
Noninvasive detection of coronary artery stenoses with multislice computed tomography or magnetic resonance imaging. Ann Intern Med (2006) 2.04
Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience. J Am Coll Cardiol (2013) 2.02
Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res (2006) 1.92
Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of Mammalian proteasomes. J Biol Chem (2003) 1.87
Ubiquitin-proteasome pathway as a new target for the prevention of restenosis. Circulation (2002) 1.75
Computed tomography angiography and myocardial computed tomography perfusion in patients with coronary stents: prospective intraindividual comparison with conventional coronary angiography. J Am Coll Cardiol (2013) 1.67
Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity. J Clin Psychopharmacol (2010) 1.66
Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany. Europace (2013) 1.63
Myocardial function in older male amateur marathon runners: assessment by tissue Doppler echocardiography, speckle tracking, and cardiac biomarkers. J Am Soc Echocardiogr (2009) 1.63
Automatic pressure titration with APAP is as effective as manual titration with CPAP in patients with obstructive sleep apnea. Respiration (2007) 1.57
Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor. Hypertension (2009) 1.54
Functional significance of a hereditary adenine insertion variant in the 5'-UTR of the endothelin-1 gene. Pharmacogenetics (2003) 1.51
Comparison of non-gated vs. electrocardiogram-gated 64-detector-row computed tomography for integrated electroanatomic mapping in patients undergoing pulmonary vein isolation. Europace (2010) 1.50
Potent anti-inflammatory effects of low-dose proteasome inhibition in the vascular system. J Mol Med (Berl) (2009) 1.49
Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy. Basic Res Cardiol (2010) 1.47
Influence of sex on outcome following transcatheter aortic valve implantation (TAVI): systematic review and meta-analysis. J Interv Cardiol (2014) 1.42
Renal sympathetic denervation: early impact on ambulatory resistant hypertension. J Clin Hypertens (Greenwich) (2014) 1.40
Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study. Stroke (2006) 1.38
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ (2010) 1.32
Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial. J Card Fail (2009) 1.26
Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection. Cardiovasc Res (2009) 1.26
Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system. Hypertension (2007) 1.26
Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system. Neuro Oncol (2012) 1.26
The role of tea and tea flavonoids in cardiovascular health. Mol Nutr Food Res (2006) 1.22
Right ventricular function assessed by two-dimensional strain and tissue Doppler echocardiography in patients with pulmonary arterial hypertension and effect of vasodilator therapy. Am J Cardiol (2006) 1.20
Contrast-enhanced MR imaging of atherosclerosis using citrate-coated superparamagnetic iron oxide nanoparticles: calcifying microvesicles as imaging target for plaque characterization. Int J Nanomedicine (2013) 1.17
Proteasome inhibitors: poisons and remedies. Med Res Rev (2008) 1.16
Prescribing of potentially inappropriate medications for the elderly: an analysis based on the PRISCUS list. Dtsch Arztebl Int (2012) 1.14
Risk of ischemic stroke in patients with Crohn's disease: a population-based nested case-control study. Inflamm Bowel Dis (2010) 1.14
Long-term up-regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin-proteasome pathway. FASEB J (2004) 1.11
Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells. Free Radic Biol Med (2006) 1.10
The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochem Biophys Res Commun (2004) 1.08
Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome. Hypertension (2004) 1.08
Inhibition of the ubiquitin-proteasome pathway induces differential heat-shock protein response in cardiomyocytes and renders early cardiac protection. Biochem Biophys Res Commun (2002) 1.08
Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation (2002) 1.08
Incidence of anogenital warts in Germany: a population-based cohort study. BMC Infect Dis (2010) 1.08
Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design. Eur J Heart Fail (2010) 1.07
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists. Mov Disord (2009) 1.06
Relaxin-a pleiotropic hormone and its emerging role for experimental and clinical therapeutics. Pharmacol Ther (2006) 1.02
Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany. J Child Adolesc Psychopharmacol (2012) 1.01
Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS). Pharmacoepidemiol Drug Saf (2012) 1.01
Comorbidities in ADHD children treated with methylphenidate: a database study. BMC Psychiatry (2013) 1.00
Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol (2002) 0.99
The ubiquitin-proteasome pathway and endothelial (dys)function. Cardiovasc Res (2009) 0.99
Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. J Am Coll Cardiol (2004) 0.99
Electron beam tomography of interpulmonary saddle embolism: extent and vascular distribution. J Comput Assist Tomogr (2002) 0.99
Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption. Am Heart J (2005) 0.98
NT-ProBNP in acute heart failure: correlation with invasively measured hemodynamic parameters during recompensation. J Card Fail (2005) 0.98
Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun (2003) 0.98
Green and black tea are equally potent stimuli of NO production and vasodilation: new insights into tea ingredients involved. Basic Res Cardiol (2008) 0.98
Alcohol consumption, genetic variants in alcohol deydrogenases, and risk of cardiovascular diseases: a prospective study and meta-analysis. PLoS One (2012) 0.98
Apical tissue tracking echocardiography for characterization of regional left ventricular function: comparison with magnetic resonance imaging in patients after myocardial infarction. J Am Soc Echocardiogr (2003) 0.98